Möller, Axel
Olsson, Henrik
Grönberg, Henrik
Eklund, Martin
Aly, Markus
Nordström, Tobias http://orcid.org/0000-0003-4915-7546
Article History
Received: 17 March 2018
Revised: 4 July 2018
Accepted: 9 July 2018
First Online: 31 August 2018
Compliance with ethical standards
:
: HG has five prostate cancer diagnostic-related patents pending, has patent applications licensed to Thermo Fisher Scientific, and might receive royalties from sales related to these patents. ME is named on four of these five patent applications. Karolinska Institutet collaborates with Thermo Fisher Scientific in developing the technology for the Stockholm3 test. The remaining authors declare that they have no conflict of interest.